Prevention of form-deprivation myopia with pirenzepine: A study of drug delivery and distribution

Ophthalmic and Physiological Optics

Volumn 19, Issue 4, 1999, Pages 327-335

  Cottriall, C L ^a   McBrien, N A ^a   Annies, R ^b   Leech, E M ^b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MUSCARINIC M1 RECEPTOR; MUSCARINIC RECEPTOR BLOCKING AGENT; PIRENZEPINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHICKEN; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; EYE; HISTOLOGY; INTRAVITREAL DRUG ADMINISTRATION; MYOPIA; NEWBORN; NONHUMAN; PLASMA; PRIORITY JOURNAL; RETINA; SUBCONJUNCTIVAL DRUG ADMINISTRATION;

ANIMALS; CHICKENS; CONJUNCTIVA; DOSE-RESPONSE RELATIONSHIP, DRUG; INJECTIONS; MUSCARINIC ANTAGONISTS; MYOPIA; PIRENZEPINE; RETINA; SENSORY DEPRIVATION; VITREOUS BODY;

EID: 0032816713     PISSN: 02755408     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0275-5408(98)00079-9     Document Type: Article

References (30)

1. Ames Iii A., Hastings A.B. Studies on water and electrolytes in nervous tissue. I. Rabbit retina: Methods and interpretation of data. J. Neurophysiol. 19:1956;201-212.
2. Bedrossian R.H. The effect of atropine on myopia. Am. J. Ophthalmol. 86:1979;713-717.
3. Carmine A.A., Brogden R.N. Pirenzepine, a review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in peptic ulcer disease and other allied diseases. Drugs. 30:1985;85-126.
4. 1 muscarinic antagonist pirenzepine reduces myopia and eye enlargement in the tree shrew. Invest. Ophthalmol. Vis. Sci. 37:1996;1368-1379.
5. Daniels, W. W. (1987). Biostatistics: a foundation for analysis in the health sciences. J Wiley, New York.
6. Gimbel H.V. The control of myopia with atropine. Canadian J. Ophthalmol. 8:1973;527-532.
7. Goyal R.K. Muscarinic receptor subtypes: physiology and clinical implications. N. Engl. J. Med. 321:1989;1022-1029.
8. Gremo F., Marchisio A.M., Vernadakis A. Muscarinic subclasses in the chick embryo retina: influence of corticosterone treatment. J. Neurochem. 45:1985;345-351.
9. 3-muscarinic receptor subtype predominates in the bovine iris sphincter smooth muscle and ciliary process. Invest. Ophthalmol. Vis. Sci. 31:1990;590-593.
10. Leech E.M., Cottriall C.L., McBrien N.A. Pirenzepine prevents form deprivation myopia in a dose dependent manner. Ophthal. Physiol. Opt. 15:1995;351-356.
11. Marzani D., Lind G.J., Chew S.J., Wallman J. The reduction of myopia by muscarinic antagonists may involve a direct effect on scleral cells. Invest. Ophthalmol. Vis. Sci. 35:(4suppl):1994;1801.
12. McBrien N.A., Moghadam H.O., Reeder A.P. Atropine reduces axial elongation and myopia in visually deprived chick eyes. Invest. Ophthalmol. Vis. Sci. 32:1991;1203. (Abstract).
13. McBrien N.A., Moghaddam H.O., Reeder A.P. Atropine reduces experimental myopia and eye enlargement via a nonaccommodative mechanism. Invest. Ophthalmol. Vis. Sci. 34:1993;205-215.
14. McBrien N.A., Moghaddam H.O., Cottriall C.L., Leech E.M., Cornell L.M. The effect of blockade of retinal cell action potentials on ocular growth, emmetropization and form deprivation myopia in young chicks. Vision Res. 35:1995;1141-1152.
15. McKanna J.A., Casagrande V.A. Atropine affects lid-suture myopia development: experimental studies of chronic atropinization in tree shrews. Doc. Ophthalmol. 28:1981;187-192.
16. McKinnon L.A., Nathanson N.M. Tissue-specific regulation of muscarinic acetylcholine receptor expression during embryonic development. J. Biol. Chem. 270:1995;20636-20642.
17. Meriney S.D., Pilar G. Cholinergic innervation of the smooth muscle cells in the choroid coat of the chick eye and its development. J. Neuroscience. 7:1987;3827-3839.
18. Pang I.H., Matsumoto S., Tamm E., DeSantis L. Characterization of muscarinic receptor involvement in human ciliary muscle cell function. J. Ocular Pharmacol. 10:1994;125-136.
19. Prast H., Fischer H.P., Prast M., Phillippu A. In vivo modulation of histamine release by autoreceptors and muscarinic acetylcholine receptors in the rat anterior hypothalamus. Naunyn-Schmiedeberg's Arch Pharmacol. 350:1994;599-604.
20. Raviola E., Wiesel T.N. An animal model of myopia. N. Engl. J. Med. 312:1985;1609-1615.
21. Rickers M., Schaeffel F. Dose-dependent effects of intravitreal pirenzepine on deprivation myopia and lens-induced refractive errors in chickens. Exp. Eye Res. 61:1995;509-516.
22. 2-receptor mechanism acting in retina or pigmented epithelium. Vis. Neuroscience. 10:1993;447-453.
23. Salceda R. Muscarinic receptors binding in retinal pigment epithelium during rat development. Neurochem. Res. 19:1994;1207-1210.
24. Seltner R.L. P., Rohrer B., Grant V., Stell W.K. Endogenous opiates in the chick retina and their role in form-deprivation myopia. Vis. Neuroscience. 14:1997;801-809.
25. Stell W.K., Miethke P., Morgan I.G. Regulation of ocular growth in chickens is unaffected by ablation of cholinergic amacrine cells. Invest. Ophthalmol. Vis. Sci. 38:1997;S759. (Abstract).
26. Stone R.A., Lin T., Laties A.M. Muscarinic antagonist effects on experimental chick myopia. Exp. Eye Res. 52:1991;755-758.
27. Troilo D., Gottlieb M.D., Wallman J. Visual deprivation causes myopia in chicks with optic nerve section. Curr. Eye Res. 6:1987;993-999.
28. 2-muscarinic receptors in calf retina membranes. Vision Res. 28:1988;247-250.
29. Watson S., Girdlestone D. 1995 Receptor and ion-channel nomenclature suppliment. Trends Pharmacol. Sci. Vol SS:1995;1-73.
30. Wildsoet, C. F., Howland, H. C., Falconer, S. and Dick, K. (1993). Chromatic aberration and accommodation: their role in emmetropization in the chick. Vision Res. 33, 1593 - 1603.